000 01278 a2200361 4500
005 20250517202014.0
264 0 _c20180320
008 201803s 0 0 eng d
022 _a1471-2415
024 7 _a10.1186/s12886-018-0679-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Changjun
245 0 0 _aDoes rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis.
_h[electronic resource]
260 _bBMC ophthalmology
_cFeb 2018
300 _a46 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review
650 0 4 _aAdult
650 0 4 _aExophthalmos
_xpathology
650 0 4 _aGraves Ophthalmopathy
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xtherapeutic use
650 0 4 _aInterleukin-6
_xmetabolism
650 0 4 _aMale
650 0 4 _aReproducibility of Results
650 0 4 _aRituximab
_xtherapeutic use
650 0 4 _aThyrotropin
_xmetabolism
700 1 _aNing, Qingyao
700 1 _aJin, Kai
700 1 _aXie, Jiajun
700 1 _aYe, Juan
773 0 _tBMC ophthalmology
_gvol. 18
_gno. 1
_gp. 46
856 4 0 _uhttps://doi.org/10.1186/s12886-018-0679-4
_zAvailable from publisher's website
999 _c28094768
_d28094768